Related Experiment Video

Updated: Jun 6, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

[Suppression of COX-2 protein to cell apoptosis in non-small cell lung cancer]

Limei Sun1, Yue Zhao, Lujian Wang

  • 1Department of Pathology, China Medical University, Shenyang, Liao-ning 110001, P.R.China.

Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|December 2, 2010
PubMed
Abstract

Insights

Cyclooxygenase-2 (COX-2) protein expression may inhibit cancer cell apoptosis in non-small cell lung cancer (NSCLC). High COX-2 levels are linked to advanced TNM stages, lymph node metastasis, and poorer prognosis, suggesting it as a potential prognostic marker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Context:

  • Carcinogenesis involves the suppression of programmed cell death (apoptosis), leading to the proliferation of abnormal cells.
  • Non-small cell lung cancer (NSCLC) is a major cause of cancer-related mortality worldwide.
  • Understanding the molecular mechanisms underlying NSCLC progression is crucial for developing effective therapeutic strategies.

Purpose:

  • To investigate the relationship between cell apoptosis and cyclooxygenase-2 (COX-2) protein expression in non-small cell lung cancer (NSCLC).
  • To evaluate the potential of COX-2 as a prognostic marker in NSCLC.

Summary:

  • This study analyzed 111 NSCLC samples for cell apoptosis, COX-2 expression, and microvessel density (MVD) using TUNEL and immunohistochemical staining.
  • A high rate of positive COX-2 expression (67.6%) was observed. COX-2 expression correlated significantly with TNM stage and lymph node metastasis.
  • Elevated MVD was found in NSCLC tissues with positive COX-2 expression. Lymph node metastasis and positive COX-2 expression were identified as independent prognostic factors.

Impact:

  • The findings suggest that COX-2 protein expression may suppress tumor cell apoptosis in NSCLC.
  • COX-2 could serve as a valuable prognostic biomarker for NSCLC patients.
  • This research contributes to understanding the role of COX-2 in lung cancer pathogenesis and progression.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...